Blog articles

NHS patients to get 'early access' to new RNA cancer vaccines

NHS cancer patients will be able to access emerging RNA-based immunotherapies thanks to a newly announced partnership between BioNTech and the government

The NHS's new strategy for genomics: Five key takeaways

We look at the new ‘Accelerating genomic medicine in the NHS’ report and what it means for healthcare professionals
A human egg being fertilised using IVF

Polygenic scores and PGT: a problematic pairing

We explore a new type of test hitting the headlines and ask whether it could ever be approved for UK clinics

Implementing genomics across the UK

We explore a new paper that sets out the UK’s genomics healthcare plan for the next three years

Personalised prescribing report: five things we learned

We share some key highlights from this week’s landmark pharmacogenomics report

Genomics Beyond Health: a new report

We step away from the healthcare sector this week to look at the bigger genomics picture
Medication on a pharmacy shelf

NHS to launch Innovative Medicines Fund

We look at an initiative that could change the lives of people with rare diseases by giving them access to cutting-edge treatments
Old pictures in a pile. No recognisable faces or text.

DTC testing: time to step in?

As DTC testing becomes more accessible and popular than ever, we ask whether more regulatory work could – and should – be done 

Genomics in the NHS

This #GenomicsConversation week, we look at the genomics landscape in the UK today and the 10-year plan for the future

AI in the NHS: what do health professionals need to know?

Can artificial intelligence help bring about personalised and preventative healthcare? AI expert Jessica Morley sums up the 4 key considerations for NHS staff

Pharmacogenomics: three challenges to the NHS

Last week we explored the promise of pharmacogenomics in the health service, but there are good reasons why it will take time to implement
cancer therapy

Pharmacogenomics: a new normal for the NHS?

The analysis of the genomic determinants of drug response is a hot topic in healthcare and was the focus for a workshop last month